[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health insider Melissa Baird filed a Form 144 notifying a proposed sale of 33,333 Class A common shares through Goldman Sachs & Co. LLC, with an aggregate market value of $1,598,650.68. The filing states the shares were acquired on 05/13/2020 as compensation via stock options and that the planned payment method is a cashless exercise/same-day sale. The document lists 217,641,958 shares outstanding for the class and discloses multiple individual sales by Ms. Baird during May–July 2025 with specific dates, share amounts and gross proceeds. No earnings, guidance or other corporate actions are included in this filing.

Positive

• None.

Negative

• The filing discloses a proposed insider sale of 33,333 Class A shares valued at $1,598,650.68 to be executed through Goldman Sachs & Co. LLC.
• The notice lists multiple individual sales by Melissa Baird during May–July 2025 with dates, share amounts and gross proceeds, indicating ongoing insider disposition of shares.

Insights

Financial Analyst

TL;DR: Insider Melissa Baird plans a Form 144 sale of 33,333 HIMS shares; transactions are disclosures of personal trading, not corporate news.

The filing notifies a planned sale of 33,333 Class A shares through Goldman Sachs with an aggregate market value of $1,598,650.68. These shares were acquired as compensation on 05/13/2020 via stock options and will be sold following a cashless exercise/same-day sale process. The form also itemizes multiple individual sales by the same person across May–July 2025, each with date, share amount and gross proceeds. From a market-impact perspective, this is an insider trading disclosure required by securities rules; it does not report operational or financial performance metrics for the company.

Corporate Governance Expert

TL;DR: The filing shows routine Rule 144 compliance and an attestation regarding nonpublic material information; it is a disclosure, not a policy change.

The filer attests they are not aware of undisclosed material adverse information and provides transaction provenance (acquired as compensation; cashless exercise). The broker listed is Goldman Sachs & Co. LLC and the planned sale date is shown as 08/12/2025. The form includes detailed historical sales by the same person over the prior months. There is no indication in the filing of a trading plan adoption date or other corporate governance actions; the submission is a regulatory notice to disclose intended insider sales under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	33333	1598650.68	217641958	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	05/13/2020	Acquired as compensation -- Stock Options	The Issuer			33333	05/13/2020	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/16/2025	5000	303098
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/08/2025	5000	250856.5
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/16/2025	8333	498800.88
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/12/2025	8333	473143.57
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/04/2025	5000	289090
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/21/2025	20000	969010
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/08/2025	8333	411970.19
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/12/2025	20000	1104788
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/12/2025	5000	289444
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/04/2025	8333	456620.9
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/04/2025	20000	1070502
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/21/2025	5000	249736.5
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/27/2025	8333	458784.15
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/27/2025	5000	277573
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/21/2025	8333	412872.65
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	07/08/2025	20000	978588
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	06/16/2025	20000	1176378
Melissa Baird 2269 Chestnut Street Suite 523 San Francisco CA 94123	Class A Common	05/27/2025	20000	1076956

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did HIMS insider file in Form 144?

Melissa Baird filed a Form 144 to notify a proposed sale of 33,333 Class A common shares via Goldman Sachs & Co. LLC with aggregate market value $1,598,650.68 and an approximate sale date of 08/12/2025.

How were the shares being sold acquired?

The shares were acquired on 05/13/2020 as compensation through stock options; the filing states the payment method is a cashless exercise/same-day sale.

Does the filing show prior sales by the same person?

Yes. The Form 144 lists multiple individual sales by Melissa Baird during May–July 2025 with specific dates, amounts and gross proceeds for each transaction.

How many Class A shares are outstanding according to the filing?

The filing reports 217,641,958 shares outstanding for the Class A common stock.

Which broker and exchange are listed for the planned sale?

The broker listed is Goldman Sachs & Co. LLC, 200 West Street, New York, NY and the exchange named is the NYSE.